A study on the effect of remimazolam on cellular immune function during the perioperative period in older adults who are having laparoscopic surgery for colorectal cancer
Frontiers in Oncology · 03.08.2026 · 16
DOI: 10.3389/fonc.2026.1827157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 03.08.2026. Verfasst von Jiafang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Wuhan No.1 Hospital, Wuhan, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
To investigate the effect of remimazolam on perioperative cellular immune function in elderly patients undergoing laparoscopic colorectal cancer surgery.
Methods
Sixty elderly patients were randomly assigned to receive either propofol (Group P, n=30) or remimazolam (Group R, n=30) for anesthesia induction and maintenance. Hemodynamic parameters, Bispectral Index (BIS), emergence time, vasopressor requirement, and adverse reactions were recorded. T lymphocyte subsets (CD3 + , CD4 + , CD8 + ) and NK cells were measured by flow cytometry at designated timepoints (T0: pre-induction; T3: 60 minutes after establishing pneumoperitoneum; T5: 5min post-extubation; T6: 24h postoperatively), and the CD4 + /CD8 + ratio was calculated.
Results
Mean arterial pressure (MAP) at T5 was significantly higher in Group R compared to Group P (P<0.05). Group R had a significantly lower intraoperative vasopressor usage rate (P<0.05) but a longer emergence time (P<0.05). CD4 + cells and the CD4 + /CD8 + ratio at T5 were significantly lower in Group R than in Group P (P<0.05). No significant differences were observed in other T-cell subsets, NK cells at other time points, intraoperative analgesic consumption, or the incidence of adverse reactions.
Conclusion
No statistically significant difference was detected between remimazolam and propofol in the primary endpoint (NK cell percentage at 24 hours postoperatively); however, this superiority-designed study was not powered to demonstrate equivalence. Remimazolam reduced intraoperative vasopressor requirement but may prolong emergence time, with a temporary decrease in CD4 + cells and CD4 + /CD8 + ratio at 5 minutes after extubation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Wuhan No.1 Hospital, Wuhan, China.
- Department of Anesthesiology, Wuhan Wuchang Hospital, Wuhan, China.
Zitieren
APA
Wang, J., Li, L., Qi, Z., & Chen, Z. (2026). A study on the effect of remimazolam on cellular immune function during the perioperative period in older adults who are having laparoscopic surgery for colorectal cancer. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1827157
Vancouver
Wang J, Li L, Qi Z, Chen Z. A study on the effect of remimazolam on cellular immune function during the perioperative period in older adults who are having laparoscopic surgery for colorectal cancer. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1827157
BibTeX
@article{Wang2026,
author = {Wang, Jiafang and Li, Lan and Qi, Zhong and Chen, Zhijun},
title = {A study on the effect of remimazolam on cellular immune function during the perioperative period in older adults who are having laparoscopic surgery for colorectal cancer},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1827157}
}
EUVIMED